Consensus and Disagreement Among Experts in Treatment of Patients With HER2+ Early-Stage Breast Cancer

Treatment options for HER2+ EBC are continuing to evolve, increasing the complexity of treatment decision making. As treatment options expand, so does the need for online decision aids. The aim of this analysis was to assess real-world global practice patterns for HER2+ EBC and compare them with recommendations from US experts based on patient cases entered by healthcare providers into an online decision support tool designed to provide specific, patient-individualized expert recommendations.


Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings